NCT02186028

Brief Summary

The purpose of the study is to evaluate the effect of daily oral supplementation with vitamin D on serum Vitamin D levels in term healthy newborns. It has been found in various studies that vitamin D is highly deficient in Indian mother infant diads. There is a need to supplement vitamin D from neonatal period to prevent various metabolic disturbances due to vitamin D deficiency in later life. This study aims to find the effectiveness and the optimum dose of routine vitamin D supplementation in healthy term newborns for fulfilling the normal requirements in Indian infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jul 2014

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 10, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

September 29, 2015

Status Verified

September 1, 2015

Enrollment Period

11 months

First QC Date

July 7, 2014

Last Update Submit

September 26, 2015

Conditions

Keywords

oral daily supplementation with vitamin D for 6 months

Outcome Measures

Primary Outcomes (1)

  • Difference in vitamin D levels attained after oral supplementation with 400IU/day Vs 200IU/day of vitamin D for 6 months

    6 months

Secondary Outcomes (1)

  • Proportion of vitamin D deficient term healthy neonates at birth

    at birth

Other Outcomes (2)

  • Proportion of neonates having vitamin D sufficiency after supplementation

    6 months

  • Proportion of neonates having vitamin D deficiency after supplementation

    6 months

Study Arms (2)

Vitamin D 400 IU

EXPERIMENTAL

Vitamin D-400IU/ml- 1ml daily Neonates will be administered Vitamin D 400 IU orally daily by the mother or other caregiver for a period of six months. The neonates will be followed up for compliance at 2 weeks, 6, 10 and 14 weeks and thereafter at 6 months of age.

Drug: Vitamin D

Vitamin D 200IU

ACTIVE COMPARATOR

Vitamin D 400IU/ml : 0.5ml daily Neonates will be administered Vitamin D 200 IU orally daily by the mother or other caregiver for a period of six months. The neonates will be followed up for compliance at 2 weeks, 6, 10 and 14 weeks and thereafter at 6 months of age.

Drug: Vitamin D

Interventions

Vit D 400 IU vs. Vit D 200 IU

Vitamin D 200IUVitamin D 400 IU

Eligibility Criteria

Age2 Hours - 48 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Gestation \> 37 weeks
  • Birth weight \>2.5 kg
  • Informed consent of one of the parents
  • Place of residence\<10km

You may not qualify if:

  • Presence of gross congenital malformation
  • Need of resuscitation at birth
  • Need for admission to neonatal ICU
  • Refusal of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kalawati Saran children's Hospital, Lady Hardinge Medical College

New Delhi, New Delhi, 110001, India

Location

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Vitamin D

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Officials

  • Sushma Nangia, MD, DM

    Lady Hardinge Medical College & Kalawati Saran Children's Hospital

    STUDY CHAIR
  • Arvind Saili, MD

    Lady Hardinge Medical College & Kalawati Saran Children's Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Sushma Nangia, M.D., D.M. (neonatology)

Study Record Dates

First Submitted

July 7, 2014

First Posted

July 10, 2014

Study Start

July 1, 2014

Primary Completion

June 1, 2015

Study Completion

July 1, 2015

Last Updated

September 29, 2015

Record last verified: 2015-09

Locations